Persistent cerebrospinal fluid tumor cells during transient radiographic response in bilateral retinoblastoma with central nervous system involvement: a pediatric case report.
- 1Department of Oncology, Children's Hospital of Kunming Medical University, Kunming Children's Hospital, Kunming, China.
- 2Department of Urology, Children's Hospital of Kunming Medical University, Kunming Children's Hospital, Kunming, China.
- 3Yunnan Key Laboratory of Children's Major Diseases Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Yunnan Clinical Medical Center for Pediatric Diseases, Kunming, China.
Abstract
Central nervous system (CNS) involvement in retinoblastoma carries a poor prognosis, and the frequency and clinical meaning of discordance between structural magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology are not well defined. This report describes a compartment-specific mixed response and emphasizes the complementary roles of MRI and serial CSF assessment. A 6-year-11-month-old boy presented after 6 months of progressive left proptosis, tearing, and conjunctival injection, without seizures or somnolence. Examination showed marked left proptosis and corneal opacity. MRI demonstrated bilateral ocular abnormalities, direct extension along the left optic nerve and chiasm, and a 29.3 mm × 25.8 mm intracranial lesion; malignant cells were present in CSF. Four cycles of vincristine, carboplatin, and etoposide reduced the intracranial lesion to 8.7 mm × 7.5 mm, but the left intraocular lesion did not clearly regress, optic nerve thickness increased from 4.9 mm after two cycles to 5.4 mm after four cycles, and CSF remained cytologically positive. Treatment was intensified for cycles 5-6 with cyclophosphamide-containing systemic chemotherapy and intrathecal methotrexate plus cytarabine. After six cycles, the intracranial lesion enlarged to 11.4 mm × 8.6 mm, optic nerve thickness increased to 6.7 mm, and CSF tumor cells persisted. Severe myelosuppression, infection, transfusion requirements, and family-related barriers prevented further treatment. The child died in March 2026, approximately 10 months after diagnosis. Germline testing prompted by bilateral disease identified a pathogenic RB1 c.772_776del (p.Asn258GlufsTer11) variant that was absent from parental blood. The early reduction in measurable intracranial tumor burden did not represent CSF clearance and was followed by radiographic progression. In selected patients with CNS-involved retinoblastoma, MRI and CSF cytology provide complementary, non-interchangeable information; this single case supports integrated reassessment but does not establish a new response protocol.
Related
- Transient tubular membrane injury is converted into persistent fibrosis through a macrophage-fibroblast relay
- Predictive value of persistent cerebrospinal fluid antibodies at 12 months for long-term clinical outcomes in pediatric anti-NMDAR encephalitis: a retrospective cohort study
- Patient and Public Involvement in designing a clinical trial for the surgical management of persistent Post-Infectious Olfactory Dysfunction
- Pulmonary tuberculosis with oral involvement presenting as persistent non-healing post-extraction lesions: a case report
- Persistent and transient senescent cells contribute to brain-barrier development
BibTeX
@article{zhu2026persistent,
title = {{Persistent cerebrospinal fluid tumor cells during transient radiographic response in bilateral retinoblastoma with central nervous system involvement: a pediatric case report.}},
author = {Jianjun Zhu and Chenghao Zhanghuang and Fengming Ji and Ye Li and Xiang Huang and Yuanhua Song and Wenling Li and Zhen Yang},
journal = {Translational pediatrics},
year = {2026},
month = sep,
doi = {10.21037/tp-2026-0637},
url = {https://europepmc.org/article/MED/42996412},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Persistent cerebrospinal fluid tumor cells during transient radiographic response in bilateral retinoblastoma with central nervous system involvement: a pediatric case report.
AU - Jianjun Zhu
AU - Chenghao Zhanghuang
AU - Fengming Ji
AU - Ye Li
AU - Xiang Huang
AU - Yuanhua Song
AU - Wenling Li
AU - Zhen Yang
PY - 2026
DA - 2026/09/29
JO - Translational pediatrics
DO - 10.21037/tp-2026-0637
UR - https://europepmc.org/article/MED/42996412
AB - Central nervous system (CNS) involvement in retinoblastoma carries a poor prognosis, and the frequency and clinical meaning of discordance between structural magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) cytology are not well defined. This report describes a compartment-specific mixed response and emphasizes the complementary roles of MRI and serial CSF assessment. A 6-year-11-month-old boy presented after 6 months of progressive left proptosis, tearing, and conjunctival injection, without seizures or somnolence. Examination showed marked left proptosis and corneal opacity. MRI demonstrated bilateral ocular abnormalities, direct extension along the left optic nerve and chiasm, and a 29.3 mm × 25.8 mm intracranial lesion; malignant cells were present in CSF. Four cycles of vincristine, carboplatin, and etoposide reduced the intracranial lesion to 8.7 mm × 7.5 mm, but the left intraocular lesion did not clearly regress, optic nerve thickness increased from 4.9 mm after two cycles to 5.4 mm after four cycles, and CSF remained cytologically positive. Treatment was intensified for cycles 5-6 with cyclophosphamide-containing systemic chemotherapy and intrathecal methotrexate plus cytarabine. After six cycles, the intracranial lesion enlarged to 11.4 mm × 8.6 mm, optic nerve thickness increased to 6.7 mm, and CSF tumor cells persisted. Severe myelosuppression, infection, transfusion requirements, and family-related barriers prevented further treatment. The child died in March 2026, approximately 10 months after diagnosis. Germline testing prompted by bilateral disease identified a pathogenic RB1 c.772_776del (p.Asn258GlufsTer11) variant that was absent from parental blood. The early reduction in measurable intracranial tumor burden did not represent CSF clearance and was followed by radiographic progression. In selected patients with CNS-involved retinoblastoma, MRI and CSF cytology provide complementary, non-interchangeable information; this single case supports integrated reassessment but does not establish a new response protocol.
SN - 2224-4336
SN - 2224-4344
ER -